UBS 18/02/2010 1 Buy $41.10 20.9%
A good operational result, obscured by swine flu and plasma margin growth with profits up 23%, UBS says.
In terms of outlook, UBS feels its all about plasma and the 4-year roll out of Privigen margin improvements.
While the 1H result was, solid, the broker feels share price gains will be step by step.
- Forums
- ASX - By Stock
- CSL
- credit suisse - $40.50
credit suisse - $40.50, page-3
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$292.52 |
Change
3.730(1.29%) |
Mkt cap ! $141.6B |
Open | High | Low | Value | Volume |
$288.51 | $293.30 | $286.92 | $143.2M | 491.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1835 | $292.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$292.55 | 508 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1835 | 292.510 |
1 | 1280 | 292.320 |
1 | 1280 | 292.120 |
1 | 1280 | 291.910 |
1 | 3366 | 291.690 |
Price($) | Vol. | No. |
---|---|---|
292.550 | 508 | 1 |
292.570 | 2 | 1 |
292.610 | 508 | 1 |
292.630 | 600 | 1 |
292.680 | 598 | 1 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |